About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 300 record(s)
Req # A-2020-03994
Copies of all analysis, correspondence, discussions, briefings and memos about the economic impact and consequences of the PMPRB regulations involving individuals with a classification of AS-04 and above, PM-04 and above, EC-04 and above, EX-all…Organization: Patented Medicine Prices Review Board Canada
November 2021
Req # A-2021-10638
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and BC Ministry of Health, Pharmaceutical Services Division over planned reforms to the PMPRB…Organization: Patented Medicine Prices Review Board Canada
November 2021
Req # A-2021-19383
The daily calendar of meetings, calls and other taskings for Douglas Clark from May 1, 2021 to October 14, 2021.Organization: Patented Medicine Prices Review Board Canada
November 2021
Req # A-2021-10631
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Amgen Canada Inc over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8,…Organization: Patented Medicine Prices Review Board Canada
November 2021
Req # A-2021-01071
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Novartis Pharmaceuticals Canada Inc. over planned reforms to the PMPRB Guidelines from June 1…Organization: Patented Medicine Prices Review Board Canada
October 2021
Req # A-2021-10625
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and AbbVie over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not…Organization: Patented Medicine Prices Review Board Canada
October 2021
Req # A-2021-10630
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and the Canadian Cancer Society over planned reforms to the PMPRB Guidelines from June 1, 2019 to…Organization: Patented Medicine Prices Review Board Canada
October 2021
Req # A-2021-10650
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and the Women's Health Coalition of Alberta Society over planned reforms to the PMPRB…Organization: Patented Medicine Prices Review Board Canada
October 2021
Req # A-2021-10661
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Collective Oncology Network for Exchange, Cancer care Innovation, Treatment Access and…Organization: Patented Medicine Prices Review Board Canada
October 2021
Req # A-2021-10672
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Pfizer Canada ULC over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8,…Organization: Patented Medicine Prices Review Board Canada
October 2021